The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues

BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most common cancers worldwide and tends to be detected at an advanced stage. More effective biomarkers for HCC screening and prognosis assessment are needed and the mechanisms of HCC require further exploration. The role of MAOA in HCC ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yu‐Yan, Li, Jian‐Di, Gao, Li, Yang, Xia, Dang, Yi‐Wu, Lai, Ze‐Feng, Liu, Li‐Min, Yang, Jie, Wu, Hua‐Yu, He, Rong‐Quan, Huang, Zhi‐Guang, Xiong, Dan‐Dan, Yang, Li‐Hua, Shi, Lin, Mo, Wei‐Jia, Tang, Deng, Lu, Hui‐Ping, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643659/
https://www.ncbi.nlm.nih.gov/pubmed/32931665
http://dx.doi.org/10.1002/cam4.3434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643659/
https://www.ncbi.nlm.nih.gov/pubmed/32931665
http://dx.doi.org/10.1002/cam4.3434

Ejemplares similares